Monday, January 11, 2021
All eyes were on Washington, D.C. last week, as news emerged Wednesday that the United States (US) Capitol was breached. Order was restored quickly and Congress moved ahead with certifying the 3 November election results. In the wake of the incident, US President Donald Trump is under pressure to resign, with just over a week remaining in his term.
COVID-19 cases continue to increase on both sides of the Atlantic Ocean, with varying levels of restrictions imposed to prevent healthcare systems from being overwhelmed. Distributing approved vaccines and inoculating citizens is proving to be a challenge in the United States and in Europe.
The coronavirus pandemic defined 2020, upending our lives and bringing unprecedented shocks to markets and investors. Next year, however, is looking a whole lot brighter.
Make no mistake: As we cross into the new year, the virus is still raging, with new infections near peaks in the U.S. and much of Europe, where millions of people are living under strict lockdowns.
The much-heralded rollout of the Covid-19 vaccines isn’t going as smoothly as hoped. The U.S. is expected to miss President Donald Trump’s target to inoculate 20 million Americans by year-end. In the European Union, there is squabbling among member states over who gets how many vaccines and when.